Showing results (31-40 of 160) with videos related to

Sort By:
Pageof 16
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|June 17, 2022
[Pilot survey on continuing education for pharmacists in Germany]Markus Alexander Müller, Melanie Astrid Scholtes, Chiara Louis, et al.
Clinical Pharmacology and Therapeutics|June 12, 2023
Physiologically Based Pharmacokinetic Modeling of Bergamottin and 6,7-Dihydroxybergamottin to Describe CYP3A4 Mediated Grapefruit-Drug InteractionsLaura Maria Fuhr, Fatima Zahra Marok, Uwe Fuhr, et al.
Clinical Pharmacokinetics|April 13, 2017
Target-Mediated Drug Disposition Pharmacokinetic-Pharmacodynamic Model of Bosentan and Endothelin-1Anke-Katrin Volz, Andreas Krause, Walter Emil Haefeli, et al.
Pharmaceutics|March 6, 2021
Pharmacokinetics of the CYP3A4 and CYP2B6 Inducer Carbamazepine and Its Drug-Drug Interaction Potential: A Physiologically Based Pharmacokinetic Modeling ApproachLaura Maria Fuhr, Fatima Zahra Marok, Nina Hanke, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
In Vitro-In Silico Modeling of Caffeine and Diclofenac Permeation in Static and Fluidic Systems with a 16HBE Lung Cell BarrierLukas Kovar, Lena Wien, Dominik Selzer, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 26, 2018
Neovascular Age-Related Macular Degeneration: A Visual Acuity Model of Natural Disease Progression and Ranibizumab Treatment EffectZufar Mulyukov, Sebastian Weber, Etienne Pigeolet, et al.
Pharmaceutics|April 3, 2021
Physiologically Based Pharmacokinetic Modeling of Bupropion and Its Metabolites in a CYP2B6 Drug-Drug-Gene Interaction NetworkFatima Zahra Marok, Laura Maria Fuhr, Nina Hanke, et al.
The AAPS Journal|April 8, 2015
Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled DrugsJens Markus Borghardt, Benjamin Weber, Alexander Staab, et al.
Infectious Disease Modelling|January 8, 2026
Integrating Kolmogorov-Arnold networks with ordinary differential equations for efficient, interpretable, and robust deep learning: Epidemiology of infectious diseases as a case studyKexin Ma, Xu Lu, Nicola Luigi Bragazzi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 10, 2016
A generic viral dynamic model to systematically characterize the interaction between oncolytic virus kinetics and tumor growthMelanie I Titze, Julia Frank, Michael Ehrhardt, et al.
Pageof 16